Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#4 most reported symptom for this vaccine
Injection site erythema has been reported 13,258 times in association with Influenza, Seasonal (Fluvirin) vaccination in VAERS. This represents 11.1% of all 119,695 reports for this vaccine.
Among these reports, 1 mentioned death (0.01%) and 286 involved hospitalization (2.2%).
Injection site erythema is the #4 most frequently reported symptom for Influenza, Seasonal (Fluvirin) out of 3021 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 13,258 reports of Injection site erythema after Influenza, Seasonal (Fluvirin) vaccination may seem alarming, but context is critical. With 119,695 total reports for this vaccine (representing many millions of doses), Injection site erythema appears in only 11.1% of reports.
The mortality rate among these reports is very low at 0.01%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.